ENTITY

Jeil Pharma Holdings (002620 KS)

6
Analysis
Health Care • South Korea
Jeil Pharma Holdings Inc. operates as a pharmaceutical manufacturing company. The Company manufactures analgesic anti-inflammatories, broad-spectrum oral antimicrobial agents, analgesic anti-cold poultice poultices, hyperlipidemia agents, intravenous antibiotics, and other products. Jeil Pharma Holdings markets its products throughout Korea.
more
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
•24 Oct 2018 01:04

Huge Spread Opening in Jeil Pharma Holdings Tender Event: Spread Is Now at +12%

Jeil Pharma Holdings (002620 KS)' swap price for the tender offer to the Jeil Pharmaceutical (271980 KS) shareholders is set at ₩23,950 based on...

Logo
601 Views
Share
bullish•Toshiba Corp
•07 Oct 2018 09:04

Last Week in Event SPACE: Toshiba, Takeda, Spring REIT, SK Holdings, IMAX, Samsung C&T

Last Week in Event SPACE ... King Streets' proposals for Toshiba Corp (6502 JP) are aggressive and overly optimistic. The 127-page document is...

Logo
774 Views
Share
•05 Oct 2018 13:16

Jeil Pharma Holdings (002620)​: ₩377bil Tender Event Summary

Jeil Pharma Holdings (002620 KS) made it official that it will target a total 7,000,000 Jeil Pharmaceutical (271980 KS) shares (47.6% of total...

Logo
658 Views
Share
bullish•Kakao Corp
•15 Sep 2017 23:20

Recap on Kakao's Sep 15 KOSPI 200 Inclusion Event

Below I summarized what appears to have happened in regard to Kakao's Sep 15 KOSPI 200 inclusion event. Kakao's KOSPI move news first broke on Apr...

Logo
443 Views
Share
x